Data Collected for Each Participant, by Study Visit
Visit 1 | Visit 2 | Visit 3 | Visit 4 | Visit 5 | Visit 6 | Visit 7 | |
---|---|---|---|---|---|---|---|
Time since randomization* (months) | Baseline | Baseline | Baseline | 6 | 6 | 12 | 12 |
Resting BP | A, B, C | A, B, C | A, B, C | A, B, C | A, B, C | A, B, C | A, B, C |
Fasting lipid profile | A, B, C | A, B, C | A, B, C | A, B, C | A, B, C | A, B, C | |
HbA1C | A, B, C | A, B, C | A, B, C | ||||
CVD history | A, B, C | ||||||
Interval CVD history | A, B, C | A, B, C | |||||
Medication review | A, B, C | A, B, C | A, B, C | ||||
Medication adherence | A, B, C | B | A, B, C | ||||
HRQL | A, B, C | A, B, C | A, B, C | ||||
Healthcare satisfaction | A, B, C | A, B, C | |||||
Health-related self-efficacy | A, B, C | B | B | ||||
Social network | A, B, C | B | A, B, C | ||||
SP qualities/involvement | A, B, C | B | A, B, C | ||||
Demographics | A, B, C | A, B, C | A, B, C |
Patient education session occurred during visit 3.
* Randomization occurred after visit 2.
BP, blood pressure; CVD, cardiovascular disease; HRQL, health-related quality of life; SP, support person; A, intervention group A; B, intervention group B; C, control group.